SEC Info - Invemed Catalyst Fund LP, et al. - ‘SC 13D/A’ on 2/15/07 re: Ambassadors Group Inc

SEC Info℠

Home

Help

Please Sign In

Invemed Catalyst Fund LP, et al. – ‘SC 13D/A’ on 2/15/07 re: Ambassadors Group Inc

On: Thursday, 2/15/07, at 5:30pm ET · Accession #: 950142-7-585 · File #: 5-78137

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/15/07  Invemed Catalyst Fund LP          SC 13D/A               1:25K  Ambassadors Group Inc             Paul Weiss Ri… LLP 01/FA
          Gladwyne Catalyst GenPar, LLC
          Invemed Catalyst Fund, L.P.
          Invemed Catalyst GenPar, LLC
          Invemed Securities, Inc.
          Kenneth G. Langone

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 2                                       11     51K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Identity and Background Interest in Securities of the Issuer Is Hereby Amended and Restated in Its Entirety as Follows: Is Hereby Amended to Include the Following Paragraph at the End: Materials to Be Filed as Exhibits Security and Issuer Source and Amount of Funds or Other Consideration
1	1st Page - Filing Submission
7	Item 1. Security and Issuer
"	Item 2. Identity and Background
"	Item 2. Is Hereby Amended and Restated in Its Entirety as Follows:
9	Item 3. Source and Amount of Funds or Other Consideration
"	Item 3. Is Hereby Amended to Include the Following Paragraph at the End:
"	Item 5. Interest in Securities of the Issuer
10	Item 7. Materials to Be Filed as Exhibits

SC 13D/A 1st Page of 11 TOC ↑Top Previous Next ↓Bottom Just 1st
 
================================================================================

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________

SCHEDULE 13D
(Rule 13d-102)

 Under the Securities Exchange Act of 1934
(Amendment No. 2)*
________________________

 AMBASSADORS GROUP, INC.
(Name of Issuer)

 COMMON STOCK, PAR VALUE $0.01 PER SHARE
(Title of Class of Securities)

 023177-10-8
(CUSIP Number)

MS. SUZANNE M. PRESENT
 INVEMED CATALYST FUND, L.P.
 375 PARK AVENUE
SUITE 2205
NEW YORK, NY 10152
TEL. NO.: (212) 843-0542
(Name, Address and Telephone Number of
Person Authorized to Receive Notices
 and Communications)
________________________

 FEBRUARY 14, 2007
(Date of Event which Requires Filing
of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this   
schedule because of Rule 13d-1(e), 1(f) or 1(g), check the following box [ ].   

Note: Schedules filed in paper format shall include a signed original and five  
copies of the schedule, including all exhibits. See Rule 13d-1(a) for other     
parties to whom copies are to be sent.                                          

*The remainder of this cover page shall be filled out for a reporting person's  
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

================================================================================

SC 13D/A 2nd Page of 11 TOC 1st Previous Next ↓Bottom Just 2nd
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  2 of 11
----------------------------------           -----------------------------------

--------------------------------------------------------------------------------
NAME OF REPORTING PERSON                                      
1        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                      

Invemed Catalyst Fund, L.P.                                   
--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)     [_]     
                                                           (b)     [X]

--------------------------------------------------------------------------------
3        SEC USE ONLY                                                           

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS                                                        

OO                                                            
--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)                                            
                                                                   [_]
--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION                                   

Delaware                                                      
--------------------------------------------------------------------------------
         7       SOLE VOTING POWER

NUMBER OF                      872,399 shares of Common Stock,
SHARES                       par value $0.01              
      BENEFICIALLY OWNED        ------------------------------------------------
BY EACH               8       SHARED VOTING POWER           
REPORTING                                                     
PERSON                       None                         
            WITH                ------------------------------------------------
              9       SOLE DISPOSITIVE POWER

                               872,399 shares of Common Stock,
               par value $0.01
                                ------------------------------------------------
                10      SHARED DISPOSITIVE POWER

    None
--------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

872,399 shares of Common Stock, par value $0.01               
--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  

                                                                   [_]
--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

4.45%                                                         
--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON                                               

PN                                                            
--------------------------------------------------------------------------------

SC 13D/A 3rd Page of 11 TOC 1st Previous Next ↓Bottom Just 3rd
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  3 of 11
----------------------------------           -----------------------------------

--------------------------------------------------------------------------------
NAME OF REPORTING PERSON                                      
1        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                      

Invemed Catalyst GenPar, LLC                                  
--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)     [_]     
                                                           (b)     [X]

--------------------------------------------------------------------------------
3        SEC USE ONLY                                                           

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS                                                        

OO                                                            
--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)                                            
                                                                   [_]
--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION                                   

Delaware                                                      
--------------------------------------------------------------------------------
         7       SOLE VOTING POWER

NUMBER OF                      872,399 shares of Common Stock,
SHARES                       par value $0.01              
      BENEFICIALLY OWNED        ------------------------------------------------
BY EACH               8       SHARED VOTING POWER           
REPORTING                                                     
PERSON                       None                         
            WITH                ------------------------------------------------
              9       SOLE DISPOSITIVE POWER

                               872,399 shares of Common Stock,
               par value $0.01
                                ------------------------------------------------
                10      SHARED DISPOSITIVE POWER

    None
--------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

872,399 shares of Common Stock, par value $0.01               
--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  

                                                                   [_]
--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

4.45%                                                         
--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON                                               

OO                                                            
--------------------------------------------------------------------------------

SC 13D/A 4th Page of 11 TOC 1st Previous Next ↓Bottom Just 4th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  4 of 11
----------------------------------           -----------------------------------

--------------------------------------------------------------------------------
NAME OF REPORTING PERSON                                      
1        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                      

Gladwyne Catalyst GenPar, LLC                                 
--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)     [_]     
                                                           (b)     [X]

--------------------------------------------------------------------------------
3        SEC USE ONLY                                                           

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS                                                        

OO                                                            
--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)                                            
                                                                   [_]
--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION                                   

Delaware                                    
--------------------------------------------------------------------------------
         7       SOLE VOTING POWER

NUMBER OF                      None                           
           SHARES               ------------------------------------------------
BENEFICIALLY OWNED        8       SHARED VOTING POWER               
BY EACH                                                     
REPORTING                      872,399 shares of Common Stock,
PERSON                       par value $0.01              
            WITH                ------------------------------------------------
              9       SOLE DISPOSITIVE POWER

    None
                                ------------------------------------------------
                10      SHARED DISPOSITIVE POWER

                               872,399 shares of Common Stock,
               par value $0.01
--------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

872,399 shares of Common Stock, par value $0.01               
--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  

                                                                   [_]
--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

4.45%                                                         
--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON                                               

OO                                                            
--------------------------------------------------------------------------------

SC 13D/A 5th Page of 11 TOC 1st Previous Next ↓Bottom Just 5th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  5 of 11
----------------------------------           -----------------------------------

--------------------------------------------------------------------------------
NAME OF REPORTING PERSON                                      
1        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                      

Invemed Securities, Inc.                                      
--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)     [_]     
                                                           (b)     [X]

--------------------------------------------------------------------------------
3        SEC USE ONLY                                                           

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS                                                        

OO                                                            
--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)                                            
                                                                   [_]
--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION                                   

New York                                                      
--------------------------------------------------------------------------------
         7       SOLE VOTING POWER

NUMBER OF                      None                           
           SHARES               ------------------------------------------------
BENEFICIALLY OWNED        8       SHARED VOTING POWER               
BY EACH                                                     
REPORTING                      872,399 shares of Common Stock,
PERSON                       par value $0.01              
            WITH                ------------------------------------------------
              9       SOLE DISPOSITIVE POWER

    None
                                ------------------------------------------------
                10      SHARED DISPOSITIVE POWER

                               872,399 shares of Common Stock,
               par value $0.01
--------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

872,399 shares of Common Stock, par value $0.01               
--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  

                                                                   [_]
--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

4.45%                                                         
--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON                                               

CO                                                            
--------------------------------------------------------------------------------

SC 13D/A 6th Page of 11 TOC 1st Previous Next ↓Bottom Just 6th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  6 of 11
----------------------------------           -----------------------------------

--------------------------------------------------------------------------------
NAME OF REPORTING PERSON                                      
1        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                      

Kenneth G. Langone                                            
--------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)     [_]     
                                                           (b)     [X]

--------------------------------------------------------------------------------
3        SEC USE ONLY                                                           

--------------------------------------------------------------------------------
4        SOURCE OF FUNDS                                                        

OO                                                            
--------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO   
ITEMS 2(d) or 2(e)                                            
                                                                   [_]
--------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OF ORGANIZATION                                   

United States                                                 
--------------------------------------------------------------------------------
         7       SOLE VOTING POWER

NUMBER OF                      None                           
           SHARES               ------------------------------------------------
BENEFICIALLY OWNED        8       SHARED VOTING POWER               
BY EACH                                                     
REPORTING                      872,399 shares of Common Stock,
PERSON                       par value $0.01              
            WITH                ------------------------------------------------
              9       SOLE DISPOSITIVE POWER

    None
                                ------------------------------------------------
                10      SHARED DISPOSITIVE POWER

                               872,399 shares of Common Stock,
               par value $0.01
--------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON           

872,399 shares of Common Stock, par value $0.01               
--------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  

                                                                   [_]
--------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                     

4.45%                                                         
--------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON                                               

IN                                                            
--------------------------------------------------------------------------------

SC 13D/A 7th Page of 11 TOC 1st Previous Next ↓Bottom Just 7th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  7 of 11
----------------------------------           -----------------------------------

ITEM 1.  SECURITY AND ISSUER.                                                   

               This  Amendment  No. 2 to Schedule 13D  ("Amendment  No. 2") is
filed by the  undersigned  to amend and supplement the Schedule 13D, dated July 
30,  2003,  as  amended  by  Amendment  No.  1  filed  February  1,  2007  (the 
"Statement"),  with respect to the shares of common stock,  par value $0.01 per 
share (the "Common Stock"), of Ambassadors Group, Inc., a Delaware  corporation 
(the "Issuer").  The principal  executive  offices of the Issuer are located at 
110 S. Ferrall Street, Spokane, WA 99202.                                       

ITEM 2.  IDENTITY AND BACKGROUND.                                               

               Item 2 is  hereby  amended  and  restated  in its  entirety  as
follows:                                                                        

               (a) Invemed Catalyst Fund, L.P., a Delaware limited partnership
(the  "Fund"),  Invemed  Catalyst  GenPar,  LLC, a Delaware  limited  liability 
company ("Catalyst GenPar"),  Gladwyne Catalyst GenPar, LLC, a Delaware limited 
liability company ("Gladwyne GenPar"), Invemed Securities,  Inc. ("Invemed"), a 
New  York  corporation,  and  Kenneth  G.  Langone  ("Langone")  are  sometimes 
hereinafter collectively referred to as the "Reporting Persons."                

               The Reporting Persons are making this joint filing because they
may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of 
the Securities  Exchange Act of 1934,  although neither the fact of this filing 
nor  anything  contained  herein  shall be  deemed  to be an  admission  by the 
Reporting Persons that a group exists.                                          

               (b)-(c) (i) The principal  business of the Fund is investing in
securities.  The business  address of the Fund is 375 Park Avenue,  Suite 2205, 
New York, New York 10152.  The general partner of the Fund is Catalyst  GenPar. 
The principal  business of Catalyst  GenPar is being the general partner of the 
Fund.                                                                           

                       (ii) The  business  address of  Catalyst  GenPar is 375
Park Avenue,  Suite 2205, New York, NY 10152.  The managing members of Catalyst 
GenPar are Gladwyne GenPar and Invemed.                                         

                       (iii) The  principal  business  of  Gladwyne  GenPar is
being a managing member of Catalyst  GenPar.  The business  address of Gladwyne 
GenPar is 645 Fifth Avenue #700, New York, NY 10022.                            

               The name,  residence  or business  address,  present  principal
occupation and citizenship of each member of Gladwyne GenPar are as follows:    

                                                        [Enlarge/Download Table]

-----------------------------------------------------------------------------------------
                          RESIDENCE OR                                                   
           NAME          BUSINESS ADDRESS      PRINCIPAL OCCUPATION          CITIZENSHIP 
-----------------------------------------------------------------------------------------
                                                                                         
Michael B. Solomon    645 Fifth Avenue #700    Managing Member of           United States
                      New York, NY 10022       Gladwyne GenPar                           
-----------------------------------------------------------------------------------------
Suzanne M. Present    645 Fifth Avenue #700    Member of Gladwyne GenPar      Australia  
                      New York, NY 10022                                                 
-----------------------------------------------------------------------------------------

SC 13D/A 8th Page of 11 TOC 1st Previous Next ↓Bottom Just 8th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  8 of 11
----------------------------------           -----------------------------------

                                                        [Enlarge/Download Table]

------------------------------------------------------------------------------------------
                          RESIDENCE OR                                                    
           NAME          BUSINESS ADDRESS      PRINCIPAL OCCUPATION          CITIZENSHIP  
------------------------------------------------------------------------------------------
                                                                                          
Kathryn Casoria       645 Fifth Avenue #700    Member of Gladwyne GenPar     United States
                      New York, NY 10022                                                  
------------------------------------------------------------------------------------------

                       (iv) Invemed's  principal business is that of a holding
company.  The business  address of Invemed is 375 Park Avenue,  Suite 2205, New 
York, NY 10152. Invemed is ultimately controlled by Kenneth G. Langone.         

               The  name,   current  business   address,   present   principal
occupation or employment and citizenship of each director and executive officer 
of Invemed Securities, Inc. are as follows:                                     

                                                        [Enlarge/Download Table]

-------------------------------------------------------------------------------------------
                          RESIDENCE OR                                                     
           NAME          BUSINESS ADDRESS      PRINCIPAL OCCUPATION          CITIZENSHIP   
-------------------------------------------------------------------------------------------
                                                                                           
Kenneth G. Langone    375 Park Avenue          Chairman of the Board and     United States 
                      Suite 2205               President,                                  
                      New York, NY  10152      Invemed Securities, Inc.                    
-------------------------------------------------------------------------------------------
Thomas Teague         Salem NationalLease      President, Salem              United States 
                      Corporation              NationalLease Corporation                   
                      P.O. Box 24788                                                       
                      Winston-Salem, NC 27114                                              
-------------------------------------------------------------------------------------------
Steven D. Holzman     375 Park Avenue          Chief Executive Officer,      United States 
                      Suite 2205               Invemed Securities, Inc.                    
                      New York, NY  10152                                                  
-------------------------------------------------------------------------------------------
G. Allen Mebane       828 Woodward Road                                      United States 
                      Mocksville, NC 27028                                                 
-------------------------------------------------------------------------------------------
John Baran            375 Park Avenue          Chief Financial Officer,      United States 
                      Suite 2205               Invemed Securities, Inc.                    
                      New York, NY  10152                                                  
-------------------------------------------------------------------------------------------

                       (v) Kenneth G. Langone's current  principal  occupation
is that of Chairman of the Board and  President  of Invemed,  and his  business 
address is 375 Park Avenue, Suite 2205, New York, NY 10152.                     

               (d)-(e)  None  of  the  Reporting   Persons  and  none  of  the
individuals  listed in this Item 2 has,  during the last five  years,  been (i) 
convicted in a criminal  proceeding  (excluding  traffic  violations or similar 
misdemeanors)  or  (ii)  a  party  to  a  civil  proceeding  of a  judicial  or 
administrative  body  of  competent  jurisdiction  and  as  a  result  of  such 
proceeding  was or is subject to a judgment,  decree or final  order  enjoining 
future violations of, or prohibited or mandating activities subject to, federal 
or state securities laws or finding any violation with respect to such laws.    

SC 13D/A 9th Page of 11 TOC 1st Previous Next ↓Bottom Just 9th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                              Page  9 of 11
----------------------------------           -----------------------------------

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.                     

               Item 3 is hereby amended to include the following  paragraph at
the end:                                                                        

               On February 13 and  February 14, 2007  Invemed  Catalyst  Fund,
L.P.  (the "Fund")  sold a total of 327,600  shares of Common Stock on the open 
market.                                                                         

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.                                  

               Item 5(a) is hereby amended to include the following  paragraph
at the end:                                                                     

               (a) On February 13, 2007, the Fund sold 91,600 shares of Common
Stock on the open market at $31.23 per share.  On February 14,  2007,  the Fund 
sold 236,000 shares of Common Stock on the open market at $30.94 per share.     

               As of the date of this Amendment,  the Fund  beneficially  owns
872,399 shares of Common Stock  constituting 4.45% of the outstanding shares of 
Common Stock of the Issuer (the percentage of shares owned is calculated  based 
upon 20,786,892  shares of Common Stock  outstanding as of October 25, 2006, as 
disclosed in the Issuer's  Form 10-Q for the quarter  ended  September 30, 2006 
filed by the Issuer on November 9, 2006).  Each of the persons listed in Item 2 
of  the  Statement  as  amended  by  this  Amendment  may  also  be  deemed  to 
beneficially  own (as that term is defined in Rule 13d-3  under the  Securities 
Exchange Act of 1934) the 872,399 shares of Common Stock  constituting 4.45% of 
the  outstanding  shares of Common  Stock of the Issuer.  However,  the persons 
listed on Item 2 of the Statement as amended by this Amendment  (other than the 
Fund) disclaim beneficial ownership of such shares of Common Stock.             

SC 13D/A 10th Page of 11 TOC 1st Previous Next ↓Bottom Just 10th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                             Page  10 of 11
----------------------------------           -----------------------------------

               Item 5(b) is hereby  amended and  restated  in its  entirety as
follows:                                                                        

               (b) The Fund has sole  power to vote and  dispose  the  872,399
shares of Common Stock reported herein. Catalyst GenPar, as the general partner 
of the Fund,  has the sole power to vote and dispose of the  872,399  shares of 
Common  Stock  owned by the Fund.  Each of  Gladwyne  GenPar  and  Invemed,  as 
managing  members of Catalyst  GenPar,  may be deemed to have shared voting and 
dispositive power over the shares of Common Stock owned by the Fund. Kenneth G. 
Langone, as the majority shareholder and Chairman of the Board and President of 
Invemed,  may be deemed to have shared  voting and  dispositive  power over the 
shares of Common Stock owned by the Fund.                                       

ITEM 7.  MATERIALS TO BE FILED AS EXHIBITS.                                     

Exhibit 1:*     Agreement relating to the filing of joint acquisition           
               statements as required by Rule 13d-1(k)(1) under the Securities
Exchange Act of 1934, as amended.               

* Previously filed.                                                             

SC 13D/A Last Page of 11 TOC 1st Previous Next ↓Bottom Just 11th
----------------------------------           -----------------------------------
CUSIP NO. 023177-10-8                                             Page  11 of 11
----------------------------------           -----------------------------------

 SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

Dated as of February 15, 2007                                                   

                   INVEMED CATALYST FUND, L.P.
                         By: INVEMED CATALYST GENPAR, LLC,
               General Partner

                                  By: GLADWYNE CATALYST GENPAR, LLC,
                       Managing Member

                                  By: /s/ Suzanne M. Present
                                               -------------------------------
                                         Name:  Suzanne M. Present
                              Title:  Member

                    INVEMED CATALYST GENPAR, LLC
                          By: GLADWYNE CATALYST GENPAR, LLC,
               Managing Member

                          By: /s/ Suzanne M. Present
                                           -----------------------------------
                                 Name:  Suzanne M. Present
                      Title:  Member

                     GLADWYNE CATALYST GENPAR, LLC

                  By: /s/ Suzanne M. Present
                                       ---------------------------------------
                         Name:  Suzanne M. Present
              Title:  Member

                INVEMED SECURITIES, INC.

                  By: /s/ Kenneth G. Langone
                                       ---------------------------------------
                        Name: Kenneth G. Langone
                            Title: Chairman of the Board
                           and President

              /s/ Kenneth G. Langone
                                   -------------------------------------------
          Kenneth G. Langone

SC 13D/A	1st Page of 11	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	6th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13D/A	7th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13D/A	8th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13D/A	9th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 9th

SC 13D/A	10th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 10th

SC 13D/A	Last Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 11th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	2/15/07	11
	2/14/07	1	9	SC 13G/A
	2/13/07	9		SC 13G/A
	2/1/07	7
	11/9/06	9		10-Q, 4, 8-K
	10/25/06	9
	9/30/06	9
	7/30/03	7		3, 4, SC 13D
				List all Filings

↑Top

Filing Submission 0000950142-07-000585 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Invemed Catalyst Fund LP, et al. – ‘SC 13D/A’ on 2/15/07 re: Ambassadors Group Inc

On: Thursday, 2/15/07, at 5:30pm ET · Accession #: 950142-7-585 · File #: 5-78137

Previous ‘SC 13D’: ‘SC 13D/A’ on 2/2/07 · Next: ‘SC 13D/A’ on 11/25/09 · Latest: ‘SC 13D/A’ on 3/3/10

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents